Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Regeneron Pharmaceuticals revenue increased from $7.9 billion in 2019 to $8.5 billion in 2020, a (8.1%) increase.

Annual Revenue ($)

Regeneron Pharmaceuticals revenue was $8.5 b in FY, 2020 which is a (8.1%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$6.71 b$7.86 b$8.5 b
Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021
Revenue$1.71 b$1.93 b$2.05 b$1.83 b$1.95 b$2.29 b$2.53 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Regeneron Pharmaceuticals revenue breakdown by business segment: 65.5% from Product Sales, 27.9% from Sanofi and Bayer Collaboration and 6.6% from Other

FY, 2020FY, 2019FY, 2018
Sanofi and Bayer Collaboration$2.37 b$2.62 b$2.19 b
Product Sales$5.57 b$4.83 b$4.11 b
Other$557 m$413.4 m$416.8 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu